Literature DB >> 31404435

Extracorporeal Membrane Oxygenation for Diffuse Alveolar Hemorrhage Caused by Idiopathic Pulmonary Hemosiderosis: A Case Report and a Review of the Literature.

Shotaro Matsumoto1, Satoshi Nakagawa1.   

Abstract

Diffuse alveolar hemorrhage (DAH) is a life-threatening condition presenting with hemoptysis, anemia, and diffuse radiographic pulmonary infiltrates; it causes acute respiratory failure. Idiopathic pulmonary hemosiderosis (IPH) is a rare cause of DAH occurring predominantly in children. Bleeding is often considered to be a contraindication for extracorporeal membrane oxygenation (ECMO) due to systemic anticoagulation. We present an 8-year-old girl with DAH caused by IPH. Unfractionated heparin was administered to maintain an activated clotting time of 150 to 180 seconds. The DAH resolved with immunosuppressive therapy, and the patient survived to decannulation. ECMO may be applied as a rescue therapy for DAH even with systemic anticoagulation.

Entities:  

Keywords:  diffuse alveolar hemorrhage; extracorporeal membrane oxygenation; idiopathic pulmonary hemosiderosis

Year:  2019        PMID: 31404435      PMCID: PMC6687456          DOI: 10.1055/s-0039-1679904

Source DB:  PubMed          Journal:  J Pediatr Intensive Care        ISSN: 2146-4626


  30 in total

Review 1.  Diffuse alveolar hemorrhage.

Authors:  Abigail R Lara; Marvin I Schwarz
Journal:  Chest       Date:  2010-05       Impact factor: 9.410

2.  Extra corporeal membrane oxygenation and plasmapheresis for pulmonary hemorrhage in microscopic polyangiitis.

Authors:  Hemant Shyam Agarwal; Mary Barraza Taylor; Marek Janusz Grzeszczak; Harold Newt Lovvorn; Tracy Earl Hunley; Kathy Jabs; Venkatramanan Shankar
Journal:  Pediatr Nephrol       Date:  2005-02-16       Impact factor: 3.714

3.  The use of extracorporeal membrane oxygenation, high-frequency oscillatory ventilation, and surfactant for the management of intraoperative acute pulmonary hemorrhage in tetralogy of Fallot.

Authors:  Meena Nathan; Meena Kalyanaraman; Jonathan Blank; Joel T Hardin; Joanne P Starr
Journal:  J Cardiothorac Vasc Anesth       Date:  2010-03-15       Impact factor: 2.628

4.  Extracorporal life support for pulmonary hemorrhage in children: a case series.

Authors:  Nikoleta S Kolovos; Douglas J E Schuerer; Frank W Moler; Susan L Bratton; Fresca Swaniker; Robert H Bartlett; Joseph R Custer; Gail Annich
Journal:  Crit Care Med       Date:  2002-03       Impact factor: 7.598

5.  Extracorporeal membrane oxygenation to rescue profound pulmonary hemorrhage due to idiopathic pulmonary hemosiderosis in a child.

Authors:  Li-Chuan Sun; Yu-Ru Tseng; Shu-Chien Huang; Pei-Ming Huang; Wen-Je Ko; Frank Leigh Lu; En-Ting Wu
Journal:  Pediatr Pulmonol       Date:  2006-09

6.  Successful use of extracorporeal life support in a hematopoietic stem cell transplant patient with diffuse alveolar hemorrhage.

Authors:  Susan H Morris; Ann E Haight; Pradip Kamat; James D Fortenberry
Journal:  Pediatr Crit Care Med       Date:  2010-01       Impact factor: 3.624

7.  Leukocytoclastic vasculitis with severe cardiac involvement in an infant: a case report.

Authors:  Jui-Tsung Hung; Yao-Hsu Yang; Cheng-Hsiang Hsiao; Hsin-Hui Yu; Jyh-Hong Lee; Li-Chieh Wang; Bor-Luen Chiang
Journal:  Clin Rheumatol       Date:  2008-03-27       Impact factor: 2.980

Review 8.  Unfractionated heparin therapy in infants and children.

Authors:  Fiona Newall; Linda Johnston; Vera Ignjatovic; Paul Monagle
Journal:  Pediatrics       Date:  2009-02-16       Impact factor: 7.124

Review 9.  Diffuse alveolar hemorrhage syndromes in children.

Authors:  Sarat C Susarla; Leland L Fan
Journal:  Curr Opin Pediatr       Date:  2007-06       Impact factor: 2.856

10.  Case report: severe microscopic polyangiitis successfully treated with extracorporeal membrane oxygenation and immunosuppression in a pediatric patient.

Authors:  Michael V Di Maria; Roger Hollister; Jon Kaufman
Journal:  Curr Opin Pediatr       Date:  2008-12       Impact factor: 2.856

View more
  2 in total

Review 1.  Proposed Pathogenesis of Diffuse Alveolar Hemorrhage in Idiopathic Pulmonary Hemosiderosis.

Authors:  Biplab K Saha; Woon H Chong; Santu Saha; Alexis Aiman; Alyssa Bonnier
Journal:  Lung       Date:  2022-03-10       Impact factor: 3.777

Review 2.  Idiopathic pulmonary hemosiderosis: a review of the treatments used during the past 30 years and future directions.

Authors:  Biplab K Saha; Nils T Milman
Journal:  Clin Rheumatol       Date:  2020-11-12       Impact factor: 3.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.